Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.560,65
0,24%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NYSE Edwards Lifesciences Corp (EW) Edwards Lifesciences Corp (EW) Notizie

Edwards Lifesciences Corp

EW
86,43
-1,58 (-1,80%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202422:15BWEdwards Lifesciences Reports First Quarter Results
18/4/202413:10BWEdwards Lifesciences to Host Earnings Conference Call on..
07/4/202422:30BWStudy of NFL Alumni Cohort Finds Majority Suffer From Heart..
11/3/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202421:11EDGAR2Form 144 - Report of proposed sale of securities
11/3/202419:00BWLarge, Real-world Studies Demonstrate Continued Excellent..
08/3/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:15EDGAR2Form 144 - Report of proposed sale of securities
05/3/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:55EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202413:05BWEdwards Lifesciences to Present at the 44th Annual TD Cowen..
21/2/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:35EDGAR2Form 144 - Report of proposed sale of securities
20/2/202423:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202400:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202421:21EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:21EDGAR2Form 144 - Report of proposed sale of securities
13/2/202422:20EDGAR2Form 144 - Report of proposed sale of securities
12/2/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:47EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202400:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202418:00EDGAR2Form 144 - Report of proposed sale of securities
06/2/202422:23EDGAR2Form 8-K - Current report
06/2/202422:15BWEdwards Lifesciences Reports Fourth Quarter Results
06/2/202400:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202413:00BWEdwards’ EVOQUE Valve Replacement System First Transcatheter..
01/2/202423:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202413:05BWEdwards Lifesciences to Host Earnings Conference Call on..
25/1/202419:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/1/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:00BWEdwards Lifesciences to Present at the 42nd Annual J.P...
29/12/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:19EDGAR2Form 144 - Report of proposed sale of securities
15/12/202323:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:03EDGAR2Form 144 - Report of proposed sale of securities
14/12/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202301:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202323:39EDGAR2Form 144 - Report of proposed sale of securities
07/12/202314:37EDGAR2Form 8-K - Current report
07/12/202314:30BWEdwards Lifesciences Outlines Growth Strategy at Annual..
Apertura: 87,00 Min: 84,71 Max: 88,38
Chiusura: 88,01

La tua Cronologia

NYSE
EW
Edwards Lifesciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network